Adma Biologics (ADMA) Operating Leases (2020 - 2025)
Adma Biologics (ADMA) posted Operating Leases of $6.6 million for Q4 2025, down 29.28% on a QoQ basis from $9.4 million in Q3 2025, and down 22.37% year-over-year from $8.6 million in Q4 2024.
Adma Biologics (ADMA) Operating Leases (2020 - 2025) Analysis & Trends
Adma Biologics' Operating Leases history runs 6 years deep, the most recent figure standing at $6.6 million for Q4 2025.
- Quarterly Operating Leases fell 22.37% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 million (down 22.37% YoY) and the FY2025 annual result came in at $6.6 million, down 22.37% from the prior year.
- Operating Leases was $6.6 million for Q4 2025 at Adma Biologics, down from $9.4 million in the prior quarter.
- Across five years, Operating Leases topped out at $10.9 million in Q2 2022 and bottomed at $6.6 million in Q4 2025.
- A 5-year average of $9.1 million and a median of $9.3 million in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases jumped 72.18% — and 2025, when it retreated 22.37%.
- Adma Biologics' Operating Leases stood at $7.5 million in 2021, then jumped by 43.44% to $10.7 million in 2022, then retreated by 8.64% to $9.8 million in 2023, then fell by 12.46% to $8.6 million in 2024, then declined by 22.37% to $6.6 million in 2025.
- Business Quant data shows ADMA's Operating Leases at $6.6 million in Q4 2025, $9.4 million in Q3 2025, and $9.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.65 Mn |
| Sep 30, 2025 | 9.40 Mn |
| Jun 30, 2025 | 9.30 Mn |
| Mar 31, 2025 | 8.30 Mn |
| Dec 31, 2024 | 8.56 Mn |
| Sep 30, 2024 | 8.87 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 9.49 Mn |
| Dec 31, 2023 | 9.78 Mn |
| Sep 30, 2023 | 9.97 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 10.47 Mn |
| Dec 31, 2022 | 10.70 Mn |
| Sep 30, 2022 | 10.64 Mn |
| Jun 30, 2022 | 10.87 Mn |
| Mar 31, 2022 | 7.28 Mn |
| Dec 31, 2021 | 7.46 Mn |
| Sep 30, 2021 | 7.40 Mn |
| Jun 30, 2021 | 7.50 Mn |
| Dec 31, 2020 | 4.33 Mn |